InvestorsHub Logo
Followers 145
Posts 6011
Boards Moderated 0
Alias Born 09/23/2009

Re: None

Wednesday, 05/05/2010 1:45:28 PM

Wednesday, May 05, 2010 1:45:28 PM

Post# of 20459
IT'S OFFICIAL! SALE APPROVED $0.40/SHARE

Innovative Health Sciences' Board of Directors Approves Sale of Company at 40 Cents per Share and Proceeds With Due Diligence
Ticker Symbol: U:IHSN


-- () --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=616158&ProfileId=051205&sourceType=1
Innovative Health Sciences, Inc. (PINKSHEETS: IHSN) commented today that the Board of Directors has accepted the offer received on April 29, 2010 from an interested party to purchase the Company. Under the terms of the offer, 100% of Innovative Health Sciences outstanding shares will be sold at a price of $0.40 per share, which is at a premium to the Company's current market price. The proposed sale is subject to close on or before June 15, 2010.

"The Board of Directors would like to reiterate that the proposed sale of the Company represents an attractive opportunity for our shareholders. The Board continues to make progress on completing their due diligence on the potential buyer and is moving forward with the sale," commented Innovative Health Sciences, Inc. President Chris Winter. The proposed sale is contingent upon the satisfactory completion of due diligence by the Board of the Company. There can be no assurances that this sale will be completed.

Management also commented on recent and unusual trading activity in its common stock. "In response to a number of inquiries regarding the trading activity in our stock, according to FINRA (http://regsho.finra.org/FORFshvol20100504.txt), it has come to our attention that roughly 25% of our total volume yesterday was in short sales," said Winter.

About Innovative Health Sciences, Inc.

Innovative Health Sciences, Inc. is focused on acquiring companies that are leaders in their respective market niches and have the potential for additional upside. Acquired in 2010, Harrington Multi Media Marketing (HM3) is a leading producer of infomercials and short-form direct television spots and developer of Internet-based marketing campaigns and transactional websites. HM3 also offers complete turnkey solutions to launch new consumer products including: assistance with outsourcing products and prototype development; set-up and management of call centers; product fulfillment and customer service; credit card processing; purchasing and management of media outlets, including telephone sales, direct response television (DRTV), and Internet sales. For more information, please call 727-230-1036 #157 or visit www.ihs-development.com.

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein.

Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact:

Chris Winter
President, Innovative Health Sciences, Inc.
Tel: 727-230-1036 #157